UroToday - Overactive Bladder (OAB)

Home

Overactive Bladder (OAB)

Overactive Bladder

UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Display

results per page

Results 271 - 285 of 371

<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Cognitive Dysfunction with Tolterodine Use - Abstract
Wednesday, 22 August 2007
Department of Obstetrics and Gynecology, University of Insubria, Del Ponte Hospital, Varese, Italy. stefanosalvatore@hotmail.com
read more

Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg - Abstract
Tuesday, 21 August 2007
Urology Research Office, Royal Hallamshire Hospital, Sheffield, UK.
read more

Long-Term Efficacy of Tolterodine and Patient Compliance in Pediatric Patients with Neurogenic Detrusor Overactivity - Abstract
Tuesday, 21 August 2007
Department of Urology, Charité - Universitatsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
read more

Age Related Pathogenesis of Nocturia in Patients with Overactive Bladder - Abstract
Monday, 20 August 2007
Weill Cornell Medical Center, New York, New York 10021, USA. urojock@aol.com
read more

Long-Term Tolerability of Tolterodine Extended Release in Children 5-11 Years of Age: Results from a 12-Month, Open-Label Study - Abstract
Monday, 20 August 2007
University Medical Centre Groningen, Groningen, The Netherlands.
read more

The Clinical Efficacy of Tolterodine Extended-Release is Maintained for 24 h in Patients with Overactive Bladder - Abstract
Friday, 17 August 2007
Department of Urology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. roger.dmochowski@vanderbilt.edu
read more

The Effects of Tolterodine on Bladder-Filling Sensations and Perception Thresholds to Intravesical Electrical Stimulation: Method and Initial Results - Abstract
Friday, 17 August 2007
Neuro-Urology, Swiss Paraplegic Center, Balgrist University Hospital, Zurich, Switzerland.
read more

Verathon Technology Challenge Award Winners Announced at AUA: Winners from VA Boston/Harvard Honored
Friday, 01 June 2007
read more

AUA 2007 Plenary Session: Presidential Address; “The Survival of Urology: Was Darwin Right?”
Thursday, 24 May 2007
read more

Society of Urologic Nurses and Associates Releases Guide for Nurses New to Operating Room
Tuesday, 24 April 2007
read more

European Urology - Acetylcholine and the Overactive Bladder
Monday, 02 April 2007
Volume 51, Issue 4, Pages 881-883 (April 2007) Currently, the most widely used and effective pharmacologic treatment for the overactive bladder (OAB) is administration of muscarinic receptor antagonists.
read more

European Urology - Transdermal Oxybutynin: Sticking to the Facts
Monday, 02 April 2007
Volume 51, Issue 4, Pages 907-914 (April 2007) Abstract - Objectives: This article critically reviews all the available published and presented data about transdermal oxybutynin to provide a summary of its efficacy, tolerability, and acceptability.
read more

European Urology - Efficacy and Tolerability of Tolterodine Extended Release in Male and Female Patients with Overactive Bladder
Monday, 02 April 2007
Volume 51, Issue 4, Pages 1054-1064 (April 2007) Abstract - Objectives: To evaluate the efficacy and tolerability of tolterodine extended release (ER) in men and women with overactive bladder (OAB).
read more

SUFU 2007 - Dorsal Genital Nerve Stimulation for the Treatment of Refractory Overactive Bladder Symptoms
Thursday, 22 March 2007
read more

SUFU 2007 - Effects of Prior Therapy on Health-Related Quality of Life Following Treatment with Transdermal Oxybutynin
Thursday, 22 March 2007

read more

Meet the Expert

Meet the Expert - Diane K. Newman

Focus on Overactive Bladder

CME Activity

Overactive Bladder Management: Thinking Beyond Urgency and Frequency

New: Poster Presentation
Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder

Review
Defining Overactive Bladder as Hypersensitivity

Review
Lower Urinary Tract Symptomatology: Its Definition and Confusion

Review
Overlap of Voiding Symptoms, Storage Symptoms and Pain in Men and Women

Review
Resiniferatoxin and Botulinum Toxin Type A for Treatment of Lower Urinary Tract Symptoms

Abstract
Anticholinergic Drugs Versus Other Medications for Overactive Bladder Syndrome in Adults

Abstract
Long-Term Darifenacin Treatment for Overactive Bladder in Patients Aged 65 Years and Older: Analysis of Results from a 2-Year, Open-Label Extension Study

Overactive Bladder Viewpoints

BJU Int Mini Reviews

- Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

- View

BJU Int Mini Reviews

- Treating Patients with Overactive Bladder Syndrome with Antimuscarinics: Heart Rate Considerations

- View